Axl is a novel target of celastrol that inhibits cell proliferation and migration, and increases the cytotoxicity of gefitinib in EGFR mutant non‑small cell lung cancer cells.

Molecular Medicine Reports
Youn Ju LeeChuhee Lee

Abstract

Gefitinib, an epidermal growth factor receptor tyrosine kinase inhibitor (EGFR‑TKI) is an excellent therapeutic agent to treat EGFR mutation‑positive non‑small cell lung cancer (NSCLC). However, the initial response decreases as chemoresistance develops. In the present study, gefitinib‑resistant EGFR mutant NSCLC PC‑9/GR cells were established to examine the characteristics and mechanisms associated with chemoresistance. Axl expression in PC‑9/GR cells was transcriptionally upregulated, since Axl protein and mRNA expression levels were identified to be increased according to western blot analysis and reverse transcription polymerase chain reaction results. The inhibitory effect of celastrol on Axl protein expression level, cell viability and clonogenicity were identified in parental and gefitinib‑resistant PC‑9 cells. In addition, treatment of PC‑9/GR cells with celastrol and gefitinib in combination was demonstrated to synergistically suppress Axl protein expression level, cell proliferation and migration. Taken together, upregulation of Axl expression seems to be associated with chemoresistance of PC‑9/GR cells. Furthermore, celastrol targets Axl to exert its anticancer effects in order to increase the susceptibility of PC‑9/...Continue Reading

References

Oct 13, 2001·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Y Yarden
Nov 26, 2003·Nihon yakurigaku zasshi. Folia pharmacologica Japonica·Seiichi YanoRui-Ping Dong
Aug 27, 2004·Proceedings of the National Academy of Sciences of the United States of America·William PaoHarold Varmus
Aug 3, 2007·The Journal of Clinical Investigation·Hongtao ZhangMark I Greene
Nov 17, 2007·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Sabiha AbbasZe'ev A Ronai
Sep 23, 2010·Cancer Research·Erinn B RankinAmato J Giaccia
Jan 14, 2012·Expert Opinion on Therapeutic Targets·Parthasarathy SeshacharyuluSurinder K Batra
Dec 15, 2012·Clinical Medicine Insights. Oncology·Takuya ArakiKoujirou Yamamoto
Jun 8, 2013·Journal of the National Comprehensive Cancer Network : JNCCN·David S EttingerUNKNOWN National comprehensive cancer network
Jun 19, 2013·Expert Review of Anticancer Therapy·Patrick M Forde, David S Ettinger
Nov 5, 2013·Cold Spring Harbor Perspectives in Biology·Greg Lemke
Nov 2, 2014·International Journal of Cancer. Journal International Du Cancer·Marco Lo IaconoGiorgio Vittorio Scagliotti
Mar 31, 2015·European Journal of Medicinal Chemistry·Wen-Jian TangJun Li
May 13, 2015·Oncotarget·Erika MartinelliFortunato Ciardiello
Aug 9, 2016·International Journal of Oncology·Su-Wei XuVincent Kam Wai Wong
Jan 21, 2017·Oncology Letters·Xiaohan QuQigang Zhang
Dec 12, 2017·Expert Opinion on Drug Metabolism & Toxicology·Gerhard Hamilton, Barbara Rath
Dec 20, 2017·Anatolian Journal of Cardiology·Xiaoyan LiDalin Jia
Jan 10, 2018·CA: a Cancer Journal for Clinicians·Rebecca L SiegelAhmedin Jemal
Jul 1, 2018·Critical Reviews in Oncology/hematology·Dharambir KashyapAnupam Bishayee

❮ Previous
Next ❯

Citations

May 7, 2020·Cell Communication and Signaling : CCS·Yunxiang ZhouAnwen Shao
Oct 20, 2020·Molecular and Cellular Biochemistry·Cleverson Moraes de OliveiraFátima Costa Rodrigues Guma
Jun 29, 2021·Frontiers in Pharmacology·Pushkaraj Rajendra WaghJeffrey Wang

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cell Migration in Cancer and Metastasis

Migration of cancer cells into surrounding tissue and the vasculature is an initial step in tumor metastasis. Discover the latest research on cell migration in cancer and metastasis here.

Cell Migration

Cell migration is involved in a variety of physiological and pathological processes such as embryonic development, cancer metastasis, blood vessel formation and remoulding, tissue regeneration, immune surveillance and inflammation. Here is the latest research.